Table 1 AGEs and the prediction of cardiovascular disease
From: The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes
Author | Year | n | FU (yr) | Tissue | Complication |
|---|---|---|---|---|---|
Simm [34] | 2007 | 75 | - | Pericardial | Perioperative cardiac events |
Koyama [71] | 2007 | 141 | 1,5 | Serum | Cardiac events (heart failure) |
Hartog [38] | 2007 | 102 | 1,7 | Serum | Cardiac events (heart failure) |
Kilhovd [37] | 2007 | 386 | 18 | Serum | Cardiac mortality |
Meerwaldt [22] | 2005 | 109 | 3 | Skin | Cardiovascular mortality |
Meerwaldt [36] | 2007 | 117 | 5 | Skin | Cardiovascular mortality |